DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hussain MHA, Powles T, Albers P. et al
Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC).
https://meetinglibrary.asco.org/record/185947/abstract ; abgerufen am 5.6.2020
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.